Vafidemstat plus standard of care for prevention of ARDS in severely ill adults with COVID-19

Phase 2, randomised, open-label trial in coronavirus disease 2019 (COVID-19) comparing Vafidemstat + standard of care with Standard of care (2 arms). Primary endpoint: Incidence requiring mechanical ventilation and ICU referral by Day 14. Started Apr 2020; status: completed.